Exercise and Cognitive Rehabilitation for Cancer Survivors
(ECO 2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate how different approaches can assist cancer survivors with memory and thinking issues after treatment. Participants will be divided into groups to test the effects of exercise, cognitive training (ECO), and a combination of both, compared to standard care. Eligible participants must have had cancer, completed primary treatments, and have concerns about memory or thinking abilities. As an unphased trial, this study provides a unique opportunity to explore innovative strategies for enhancing cognitive health post-cancer treatment.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it does allow patients on endocrine therapies to enroll. It's best to discuss your specific medications with the trial team.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Previous studies have generally found exercise programs like EXCAP to be safe for cancer survivors. Research shows that exercise can improve health and help manage side effects. Survivors often benefit from exercise plans tailored to their needs.
Specific safety data for MAAT is limited, but similar therapies have been well-received. MAAT aims to enhance memory and attention through brain training, which has shown promise in helping cancer survivors think more clearly.
The ECO program combines exercise and brain training. Exercise is linked to better overall health and reduced cancer-related fatigue. While detailed safety data on ECO isn't available, exercise and brain training are generally safe and well-tolerated for cancer survivors.
Overall, these activities have been shown to be safe in similar settings, offering potential benefits for health and cognitive skills.12345Why are researchers excited about this trial's treatments?
Researchers are excited about the Exercise and Cognitive Rehabilitation treatments because they offer a fresh approach to helping cancer survivors. Unlike standard care, which often focuses on medication and traditional therapies, these treatments integrate physical exercise and cognitive training. The EXCAP program is unique because it combines home-based walking and resistance exercises with digital health tools to monitor progress and tackle barriers. Meanwhile, the MAAT intervention uses cognitive behavioral therapy principles to improve memory and attention, teaching stress management and coping skills. Together, these treatments aim to enhance both physical and cognitive health, offering a comprehensive way to improve the overall well-being of cancer survivors.
What evidence suggests that this trial's treatments could be effective for cancer survivors?
Research shows that exercise can enhance thinking and memory in cancer survivors. Studies indicate that exercise improves brain function test results and boosts self-reported mental abilities. In this trial, participants may join the EXCAP program, which has demonstrated benefits like improved quality of life and reduced fatigue. Meanwhile, some participants will receive MAAT, which effectively aids cancer survivors with memory and attention issues. Others will participate in the ECO program, which combines exercise with brain training and has shown promise in enhancing mental function and overall well-being. These findings suggest that these activities could improve thinking and memory for cancer survivors.678910
Who Is on the Research Team?
Kah Poh Loh
Principal Investigator
University of Rochester
Are You a Good Fit for This Trial?
This trial is for older cancer survivors aged 65 or above who have finished curative treatments, including those on endocrine therapies or post-stem cell transplant. Participants should be concerned about their memory or thinking abilities post-treatment, able to speak English, and physically capable of walking and exercising without medical contraindications.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the integrated EXCAP and MAAT interventions over a 12-week period
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- ECO
- EXCAP
- MAAT
Trial Overview
The study compares the effects of three interventions: an integrated exercise and cognitive rehab program (ECO), an exercise-only intervention (EXCAP), and a cognitive rehab-only intervention (MAAT) against usual care in improving cognition as measured by the Trail Making Test.
How Is the Trial Designed?
4
Treatment groups
Experimental Treatment
Active Control
Memory and Attention Adaptation Training (MAAT) is an intervention based on cognitive behavioral therapy principles that integrates cognitive rehabilitation skills and provides education and training in adaptive behavioral coping skills, stress management techniques, and compensation strategies to address CRCD.
Exercise for Cancer Patients (EXCAP) is an individually tailored, low-to-moderate intensity, home-based walking and progressive resistance exercise program designed for patients with cancer delivered by an exercise physiologist. It also includes digital health applications, allowing the tracking of exercise adherence, barriers to exercise, and symptoms.
Patients will receive the integrated EXCAP and MAAT interventions.
Patients in the control group will receive care as usual.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Rochester
Lead Sponsor
Citations
Effects of physical exercise on cognitive function of breast ...
Physical exercise can improve cognitive function for breast cancer survivors, particularly in self-reported cognitive function, and executive function.
Effect of exercise interventions on cognitive function in breast ...
Overall, exercise demonstrated a positive small effect size on cognitive function in breast cancer patients and survivors (g = 0.22; 95% ...
Impact of increasing physical activity on cognitive ...
Preliminary research suggests that in cancer patients, higher levels of physical activity are related to better outcomes on neuropsychological tests [14], [15], ...
4.
journals.lww.com
journals.lww.com/ajpmr/fulltext/2024/09000/comparative_effects_of_exercise_interventions_and.3.aspxComparative Effects of Exercise Interventions and...
Exercise is a low-cost intervention, which has been shown to positively impact cognitive impairment in breast cancer survivors with minimal risk to patients.
Relationship of physical activity and cognitive functioning ...
Greater physical activity was associated with faster processing speed in participants closer in time to their cancer diagnosis. These results ...
Protocol for the Exercise, Cancer and Cognition – The ECCO ...
Epidemiological studies show that increased physical activity is linked to a lower risk of breast cancer and mortality.
Can Exercise Improve Cancer Associated Cognitive ...
To knowledge of the investigators this is the first study to examine the effect of an exercise intervention on cognitive function in breast cancer survivors.
Changes in physical activity, sedentary behavior, and self- ...
A recent systematic review found that 12 out of 28 randomized control trials reported a significant improvement in self-reported cognitive function among cancer ...
Editorial: Physical activity and cancer-associated cognitive ...
Among cancer survivors, evidence-based exercise guidelines are available for risk factors of CACD, such as cancer-related fatigue and ...
Impact of exercise on health outcomes in people with cancer
Conclusion Exercise reduces adverse events and enhances well-being through a range of health outcomes in people with cancer. Meta-analysis; Exercise; Randomised ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.